Di Tomaso, Emmanuelle,Germa, Marie-Caroline,Massacesi, Cristian,Fritsch, Christine,Schnell, Christian Rene,Tavorath, Ranjana
申请号：
AU2014358773
公开号：
AU2014358773A1
申请日:
2014.12.03
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof for use in methods of treating or preventing a proliferative disease in a patient in need thereof by orally administering a therapeutically effective amount of said compound for at least two five-consecutive day cycles, wherein said compound is not administered to the patient for a period of about two days to about three days between said five-consecutive day cycles.
